NVRI:NYSEEnviri Corporation Analysis
Data as of 2026-08-21 - not real-time
$20.31
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Enviri Corporation trades at $20.31, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it lost 11.4%. With RSI at 42.3 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $19.36 and resistance around $24.20.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 41.1% above where the shares trade now. Revenue is contracting at 66.7% on a -24.4% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 47.0%, a beta of 0.95 and a maximum drawdown of 17.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 41.1% above where the shares trade now. Revenue is contracting at 66.7% on a -24.4% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 47.0%, a beta of 0.95 and a maximum drawdown of 17.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Top Market Events
Enviri Corporation NYSE:NVRI shares slipped slightly in pre-market trading on Tuesday after the company reported a...Strong performance at Harsco Environmental and Rail, with each exceeding expectations in the quarterStrategic decision...Kalkine Media9dEnviri NYSE:NVRI : What Could Today’s Update Reveal About Industrial Environmental Services And Cost...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading above the 200-day average of 19.14
- MACD momentum is negative
- 30-day price change of -11.4%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Trading above the 200-day average of 19.14
- Analyst targets imply +41.1% versus the current price
- 30-day volatility of 47.0%
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -24.4%
- Analyst targets imply +41.1% versus the current price
- Negative return on equity of -78.1%
Key Metrics & Analysis
Financial Health
Revenue Growth-66.70%
Profit Margin-24.38%
P/E Ratio-19.0
ROE-78.08%
ROA-3.83%
Debt/Equity61.56
P/B Ratio0.9
Op. Cash Flow$-202568000
Free Cash Flow$-482875
Industry P/E29.8
Technical Analysis
TrendNeutral
RSI42.3
Support$19.36
Resistance$24.20
MA 20$21.61
MA 50$21.91
MA 200$19.14
MACDBearish
VolumeIncreasing
Fear & Greed Index92.84
Valuation
Target Price$28.67
Upside/Downside41.15%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.95
Volatility47.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.